Literature DB >> 11072784

Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study.

G L Ottesen1, H P Graversen, M Blichert-Toft, I J Christensen, J A Andersen.   

Abstract

In a Danish nationwide prospective study of in situ carcinoma of the breast, a total of 275 women, treated with excision alone, were registered from 1982 to 1989. The series included 142 cases of ductal carcinoma in situ (DCIS), 100 cases of lobular carcinoma in situ (LCIS), 26 cases of DCIS+LCIS, and seven cases of atypical hyperplasia (AH). Within a median follow-up of 120 months, a crude recurrence rate of 28% (76 cases) was found, of which 53% (40 cases) recurred as invasive carcinomas (IC) and 47% (36 cases) as CIS. CIS recurrences appeared after median 18 months, compared to median 42 months for IC recurrences. No statistical difference was found with respect to development of IC between the three groups of DCIS, DCIS+LCIS, and LCIS. The majority of recurrences were ipsilateral, also for LCIS. Forty four of 49 recurrences following DCIS, and seven of nine recurrences following DCIS+LCIS occurred as local recurrences. Histopathologically, in DCIS a strong association was found between large nuclear size and comedonecrosis. Univariate analysis showed a significant association to recurrence for nuclear size, comedonecrosis, and size of the original lesion. Multivariate analysis showed that only comedonecrosis and size of lesion were independent predictors of recurrence, however, specimen margins were not included in the analysis, as this parameter could not be adequately evaluated in the present series. Nuclear size of original DCIS lesion was related to histologic grade of the IC recurrence. The recurrence rate for DCIS of small nuclear size increased from 6% at five years of follow-up to 16% at 10 years, possibly due to a slower growth rate and a continued but delayed risk. Similarities were found between LCIS and DCIS of small nuclear size, both showing a continued risk and comparable rate of recurrence. Further, progression to IC of similar, highly differentiated type was seen, indicating a linkage between biological behavior of the two histological types.

Entities:  

Mesh:

Year:  2000        PMID: 11072784     DOI: 10.1023/a:1006453915590

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  23 in total

Review 1.  Significance of lobular intraepithelial neoplasia at margins of breast conservation specimens: a report of 38 cases and literature review.

Authors:  Sophia K Apple; Mahan Matin; Eric P Olsen; Neda A Moatamed
Journal:  Diagn Pathol       Date:  2010-08-20       Impact factor: 2.644

Review 2.  DCIS, cytokeratins, and the theory of the sick lobe.

Authors:  Tibor Tot
Journal:  Virchows Arch       Date:  2005-05-31       Impact factor: 4.064

3.  Risk of Contralateral Breast Cancer in Women with Ductal Carcinoma In Situ Associated with Synchronous Ipsilateral Lobular Carcinoma In Situ.

Authors:  Megan E Miller; Shirin Muhsen; Emily C Zabor; Jessica Flynn; Cristina Olcese; Dilip Giri; Kimberly J Van Zee; Melissa Pilewskie
Journal:  Ann Surg Oncol       Date:  2019-09-24       Impact factor: 5.344

4.  Biofunctional characteristics of in situ and invasive breast carcinoma.

Authors:  Sara Bravaccini; Anna Maria Granato; Laura Medri; Flavia Foca; Fabio Falcini; Wainer Zoli; Monica Ricci; Giuseppe Lanzanova; Nestory Masalu; Luigi Serra; Federico Buggi; Secondo Folli; Rosella Silvestrini; Dino Amadori
Journal:  Cell Oncol (Dordr)       Date:  2013-06-27       Impact factor: 6.730

Review 5.  Association between patient and tumor characteristics with clinical outcomes in women with ductal carcinoma in situ.

Authors:  Tatyana Shamliyan; Shi-Yi Wang; Beth A Virnig; Todd M Tuttle; Robert L Kane
Journal:  J Natl Cancer Inst Monogr       Date:  2010

6.  A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial.

Authors:  S E Pinder; C Duggan; I O Ellis; J Cuzick; J F Forbes; H Bishop; I S Fentiman; W D George
Journal:  Br J Cancer       Date:  2010-06-01       Impact factor: 7.640

7.  Diagnostic utility of E-cadherin and P120 catenin cocktail immunostain in distinguishing DCIS from LCIS.

Authors:  Xiaoxian Li; Mary R Schwartz; Jae Ro; Candice R Hamilton; Alberto G Ayala; Luan D Truong; Qihui Jim Zhai
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

Review 8.  The role of radiotherapy in the conservative treatment of ductal carcinoma in situ of the breast.

Authors:  Csaba Polgár; Zsuzsanna Kahán; Zsolt Orosz; Gabriella Gábor; Janaki Hadijev; Gábor Cserni; Janina Kulka; Nóra Jani; Zoltán Sulyok; György Lázár; Gábor Boross; Csaba Diczházi; Eva Szabó; Zsolt László; Zoltán Péntek; Tibor Major; János Fodor
Journal:  Pathol Oncol Res       Date:  2008-04-26       Impact factor: 3.201

9.  Investigational Paradigms in Downscoring and Upscoring DCIS: Surgical Management Review.

Authors:  P Orsaria; A V Granai; D Venditti; G Petrella; O Buonomo
Journal:  Int J Surg Oncol       Date:  2012-05-16

10.  Serial analysis of gene expression of lobular carcinoma in situ identifies down regulation of claudin 4 and overexpression of matrix metalloproteinase 9.

Authors:  Dengfeng Cao; Kornelia Polyak; Marc K Halushka; Hind Nassar; Nina Kouprina; Christine Iacobuzio-Donahue; Xinyan Wu; Saraswati Sukumar; Jessica Hicks; Angelo De Marzo; Pedram Argani
Journal:  Breast Cancer Res       Date:  2008-10-27       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.